[Commons-Law] I-MAK Challenges Patents on Lifesaving HIV Drug Combination in Europe, India

[Tahir Amin]

August 16, 2007

New York – Today, a U.S.-based non-profit organization, the Initiative for
Medicines, Access & Knowledge (I-MAK) announced its filings of critical
patent challenges on the HIV drug combination Lopinavir/Ritonavir. This drug
combination is manufactured and sold by U.S. drug company Abbott
Laboratories under the brand name Aluvia(r). I-MAK's patent submissions were
filed at the European Patent Office and the Indian Patent Office.

For more information on the filing, please visit
www.i-mak.org/i-mak-news-updates/.

For a summary of key arguments or the documents, please visit
www.i-mak.org/lopinavirritonavir.

*
* *

*


-- 
Tahir Amin
Initiative for Medicines, Access & Knowledge (I-MAK)
+44 771 853 9472
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://mail.sarai.net/pipermail/commons-law/attachments/20070816/71ac5aa5/attachment.html